In breast tumors, expression analysis of RAD51/TODRA, E2F1 and TPIP shows perturbed regulation of RAD51 expression, and the associated increase in RAD51 expression correlates with an aggressive tumor phenotype. This evidence concerns the gene E2F1 and breast neoplasm.